News | August 18, 2010

AHA Says Cardiac Computed Tomography is Safe, Accurate, Cost-Effective


August 18, 2010 - Cardiac computed tomography (CT) was found to be safe, accurate, and cost-effective in low risk patients in a recent scientific statement published by the American Heart Association (AHA), titled “Testing of Low-Risk Patients Presenting to the Emergency Department With Chest Pain.”

The paper summarizes the use of cardiac CT angiography as “Computed tomography coronary angiography has also shown promise in this setting. A negative accelerated diagnostic protocol evaluation allows discharge, whereas patients with positive findings are admitted. This approach has been found to be safe, accurate, and cost-effective in low-risk patients presenting with chest pain.”

The use of CT angiography is rapidly expanding, primarily due to well-published studies demonstrating cost effectiveness and safety in this population. Hospitals and cardiologists are increasingly turning to this test to determine who of those presenting to the emergency room can be safely discharged from the hospital in a timely fashion.

New, large randomized studies that were already presented, but not yet published, further reinforce the utility of this modality and the safety, efficacy and cost savings compared to other imaging tests.

These guidelines, in association with NICE guidelines recently published on the same topic, reiterate the important and growing role of cardiac CT angiography and calcium scoring as rapid methods to triage patients in the emergency department safely and most cost-effectively than other imaging modalities," said Matthew J. Budoff, M.D., FSCCT, professor of medicine at the David Geffen School of Medicine at UCLA, director of cardiac CT at Los Angeles Biomedical Research Center at Harbor UCLA Medical Center in Torrance, CA and president of the Society of Cardiovascular Computed Tomography (SCCT).

For more information: www.SCCT.org


Related Content

News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

Home April 08, 2024
Home
Subscribe Now